Trial NCT01935947

View at ClinicalTrials.gov 
Aliases: NCT01846897
Org. Study IDs: NCI-2013-00949
Secondary IDs: 9253 NA_00081948 NA_00081948/J1309 NCI-2013-00949 P30CA006973

Last trial update was posted on 2018-07-27

MeSH Interventions

Azacitidine Camptothecin Docetaxel Entinostat Gemcitabine Histone Deacetylase Inhibitors Irinotecan Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Recurrent Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer

Stopping Reasons

N/A

Limitations And Caveats

Low recruitment lead to slow accrual. Not having enough patients on the trial and high disease progression lead to closing the study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID